October 24, 2017 7:52 AM ET


Company Overview of Kadmus Pharmaceuticals, Inc.

Key Executives for Kadmus Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Kelvin W. Gee Ph.D.12 RelationshipsFounder64
Tim Compton No RelationshipsDirector of Analytical Development--
Roger Mailhot Ph.D.No RelationshipsVP of Research & Development of Canada--

Kadmus Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert G. McNeil Ph.D. 35 RelationshipsDalCor Pharmaceuticals Canada Inc.73
Jeffrey T. Courtney 23 RelationshipsOntario Institute For Cancer Research--
Mark A. Cochran Ph.D. 39 RelationshipsMicrobix Biosystems Inc.--
Annette M. Bianchi 12 RelationshipsNeuraltus Pharmaceuticals, Inc.--
View All Board Members

Kadmus Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Kadmus Pharmaceuticals, Inc. CEO Compensation
Industry Average


Phylogica Limited Announces Board Changes
October 23, 2017 4:39 AM ET
Benitec Biopharma Limited Announces Resignation of John Chiplin as Director
October 23, 2017 3:54 AM ET
Verseon Corporation Appoints Robert W. Karr as Non-Executive Class II Director
October 20, 2017 6:00 AM ET
Neurocrine Biosciences, Inc. Announces Management Changes
October 19, 2017 9:26 PM ET
AveXis, Inc. Announces Management Changes
October 19, 2017 8:58 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kadmus Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.